234 related articles for article (PubMed ID: 15080792)
41. Calmodulin binds HER2 and modulates HER2 signaling.
White CD; Li Z; Sacks DB
Biochim Biophys Acta; 2011 May; 1813(5):1074-82. PubMed ID: 21185879
[TBL] [Abstract][Full Text] [Related]
42. Direct binding of Copine3 with Jab1 activates downstream ErbB2 signaling and motility in SKBr3 breast cancer cells.
Choi HY; Park N; Na JB; Ko ES; Park JY; Yoo JC
Oncol Rep; 2016 Feb; 35(2):1147-52. PubMed ID: 26719032
[TBL] [Abstract][Full Text] [Related]
43. Protein-tyrosine phosphatase PTPN9 negatively regulates ErbB2 and epidermal growth factor receptor signaling in breast cancer cells.
Yuan T; Wang Y; Zhao ZJ; Gu H
J Biol Chem; 2010 May; 285(20):14861-14870. PubMed ID: 20335174
[TBL] [Abstract][Full Text] [Related]
44. Evidence for the direct interaction between calmodulin and the human epidermal growth factor receptor.
Li H; Villalobo A
Biochem J; 2002 Mar; 362(Pt 2):499-505. PubMed ID: 11853560
[TBL] [Abstract][Full Text] [Related]
45. Calcium fingerprints induced by calmodulin interactors in eukaryotic cells.
Dagher R; Brière C; Fève M; Zeniou M; Pigault C; Mazars C; Chneiweiss H; Ranjeva R; Kilhoffer MC; Haiech J
Biochim Biophys Acta; 2009 Jun; 1793(6):1068-77. PubMed ID: 19133300
[TBL] [Abstract][Full Text] [Related]
46. Calmodulin modulates Akt activity in human breast cancer cell lines.
Coticchia CM; Revankar CM; Deb TB; Dickson RB; Johnson MD
Breast Cancer Res Treat; 2009 Jun; 115(3):545-60. PubMed ID: 18587642
[TBL] [Abstract][Full Text] [Related]
47. Deletion of the calmodulin-binding domain of Grb7 impairs cell attachment to the extracellular matrix and migration.
García-Palmero I; Villalobo A
Biochem Biophys Res Commun; 2013 Jun; 436(2):271-7. PubMed ID: 23743201
[TBL] [Abstract][Full Text] [Related]
48. Carbachol stimulates binding of a photoreactive calmodulin derivative to calmodulin-binding proteins in intact SK-N-SH human neuroblastoma cells.
Mangels LA; Gnegy ME
J Biol Chem; 1992 Mar; 267(9):5847-54. PubMed ID: 1556101
[TBL] [Abstract][Full Text] [Related]
49. Calmodulin and Ca2+/calmodulin-binding proteins are involved in Tetrahymena thermophila phagocytosis.
Gonda K; Komatsu M; Numata O
Cell Struct Funct; 2000 Aug; 25(4):243-51. PubMed ID: 11129794
[TBL] [Abstract][Full Text] [Related]
50. Regulation of platelet Rac1 and Cdc42 activation through interaction with calmodulin.
Elsaraj SM; Bhullar RP
Biochim Biophys Acta; 2008 May; 1783(5):770-8. PubMed ID: 18328269
[TBL] [Abstract][Full Text] [Related]
51. Regulation of the ligand-dependent activation of the epidermal growth factor receptor by calmodulin.
Li H; Panina S; Kaur A; Ruano MJ; Sánchez-González P; la Cour JM; Stephan A; Olesen UH; Berchtold MW; Villalobo A
J Biol Chem; 2012 Jan; 287(5):3273-81. PubMed ID: 22157759
[TBL] [Abstract][Full Text] [Related]
52. Calmodulin modulates insect odorant receptor function.
Mukunda L; Miazzi F; Kaltofen S; Hansson BS; Wicher D
Cell Calcium; 2014 Apr; 55(4):191-9. PubMed ID: 24661599
[TBL] [Abstract][Full Text] [Related]
53. Identification of a small peptide that inhibits the phosphorylation of ErbB2 and proliferation of ErbB2 overexpressing breast cancer cells.
Pero SC; Shukla GS; Armstrong AL; Peterson D; Fuller SP; Godin K; Kingsley-Richards SL; Weaver DL; Bond J; Krag DN
Int J Cancer; 2004 Oct; 111(6):951-60. PubMed ID: 15300809
[TBL] [Abstract][Full Text] [Related]
54. In vitro interaction of estradiol receptor with Ca2+-calmodulin.
Castoria G; Migliaccio A; Nola E; Auricchio F
Mol Endocrinol; 1988 Feb; 2(2):167-74. PubMed ID: 3398848
[TBL] [Abstract][Full Text] [Related]
55. Ca2+/calmodulin-based signalling in the regulation of the muscle fibre phenotype and its therapeutic potential via modulation of utrophin A and myostatin expression.
Michel RN; Chin ER; Chakkalakal JV; Eibl JK; Jasmin BJ
Appl Physiol Nutr Metab; 2007 Oct; 32(5):921-9. PubMed ID: 18059617
[TBL] [Abstract][Full Text] [Related]
56. Novel luciferase-based reporter system to monitor activation of ErbB2/Her2/neu pathway noninvasively during radiotherapy.
Wolf F; Li W; Li F; Li CY
Int J Radiat Oncol Biol Phys; 2011 Jan; 79(1):233-8. PubMed ID: 20934271
[TBL] [Abstract][Full Text] [Related]
57. Feedback control of ErbB2 via ERK-mediated phosphorylation of a conserved threonine in the juxtamembrane domain.
Kawasaki Y; Sakimura A; Park CM; Tomaru R; Tanaka T; Ozawa T; Zhou Y; Narita K; Kishi H; Muraguchi A; Sakurai H
Sci Rep; 2016 Aug; 6():31502. PubMed ID: 27531070
[TBL] [Abstract][Full Text] [Related]
58. The extracellular domain of p185(c-neu) induces density-dependent inhibition of cell growth in malignant mesothelioma cells and reduces growth of mesothelioma in vivo.
Yoneda T; Kumagai T; Nagatomo I; Furukawa M; Yamane H; Hoshino S; Mori M; Takeda Y; Horai T; Nishida S; Watanabe D; Kijima T; Yoshida M; Osaki T; Tachibana I; Greene MI; Kawase I
DNA Cell Biol; 2006 Sep; 25(9):530-40. PubMed ID: 16989576
[TBL] [Abstract][Full Text] [Related]
59. Regulation of calmodulin binding to P-57. A neurospecific calmodulin binding protein.
Alexander KA; Cimler BM; Meier KE; Storm DR
J Biol Chem; 1987 May; 262(13):6108-13. PubMed ID: 2952648
[TBL] [Abstract][Full Text] [Related]
60. Dual inhibition of ErbB1 and ErbB2 in cancer by recombinant human prolidase mutant hPEPD-G278D.
Yang L; Li Y; Bhattacharya A; Zhang Y
Oncotarget; 2016 Jul; 7(27):42340-42352. PubMed ID: 27286447
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
